GILEAD SCIENCES INC (1GILD.MI) Fundamental Analysis & Valuation

BIT:1GILD • US3755581036

Current stock price

118.84 EUR
-9.48 (-7.39%)
Last:

This 1GILD.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. 1GILD.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1GILD was profitable.
  • 1GILD had a positive operating cash flow in the past year.
  • In the past 5 years 1GILD has always been profitable.
  • 1GILD had a positive operating cash flow in each of the past 5 years.
1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCF1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • 1GILD has a Return On Assets of 13.86%. This is amongst the best in the industry. 1GILD outperforms 89.16% of its industry peers.
  • With an excellent Return On Equity value of 37.80%, 1GILD belongs to the best of the industry, outperforming 95.18% of the companies in the same industry.
  • 1GILD's Return On Invested Capital of 18.54% is amongst the best of the industry. 1GILD outperforms 96.39% of its industry peers.
  • 1GILD had an Average Return On Invested Capital over the past 3 years of 16.22%. This is significantly above the industry average of 10.61%.
  • The last Return On Invested Capital (18.54%) for 1GILD is above the 3 year average (16.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
1GILD.MI Yearly ROA, ROE, ROIC1GILD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • 1GILD has a Profit Margin of 27.88%. This is amongst the best in the industry. 1GILD outperforms 83.13% of its industry peers.
  • In the last couple of years the Profit Margin of 1GILD has declined.
  • 1GILD has a better Operating Margin (38.96%) than 90.36% of its industry peers.
  • 1GILD's Operating Margin has improved in the last couple of years.
  • 1GILD has a better Gross Margin (78.72%) than 65.06% of its industry peers.
  • In the last couple of years the Gross Margin of 1GILD has remained more or less at the same level.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
1GILD.MI Yearly Profit, Operating, Gross Margins1GILD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. 1GILD.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1GILD is creating value.
  • The number of shares outstanding for 1GILD has been reduced compared to 1 year ago.
  • The number of shares outstanding for 1GILD has been reduced compared to 5 years ago.
  • Compared to 1 year ago, 1GILD has an improved debt to assets ratio.
1GILD.MI Yearly Shares Outstanding1GILD.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1GILD.MI Yearly Total Debt VS Total Assets1GILD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • 1GILD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC2.2
WACC8.41%
1GILD.MI Yearly LT Debt VS Equity VS FCF1GILD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that 1GILD should not have too much problems paying its short term obligations.
  • 1GILD has a worse Current ratio (1.53) than 60.24% of its industry peers.
  • 1GILD has a Quick Ratio of 1.17. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.17, 1GILD is not doing good in the industry: 62.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
1GILD.MI Yearly Current Assets VS Current Liabilites1GILD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1GILD.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.79% over the past year.
  • 1GILD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.83% yearly.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%

3.2 Future

  • Based on estimates for the next years, 1GILD will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.47% on average per year.
  • Based on estimates for the next years, 1GILD will show a small growth in Revenue. The Revenue will grow by 4.32% on average per year.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
1GILD.MI Yearly Revenue VS Estimates1GILD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
1GILD.MI Yearly EPS VS Estimates1GILD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. 1GILD.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.83, 1GILD is valued correctly.
  • 84.34% of the companies in the same industry are more expensive than 1GILD, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.61, 1GILD is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 15.38 indicates a correct valuation of 1GILD.
  • 1GILD's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1GILD is cheaper than 92.77% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.79, 1GILD is valued a bit cheaper.
Industry RankSector Rank
PE 16.83
Fwd PE 15.38
1GILD.MI Price Earnings VS Forward Price Earnings1GILD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 84.34% of the companies in the same industry are more expensive than 1GILD, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1GILD indicates a rather cheap valuation: 1GILD is cheaper than 90.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.88
EV/EBITDA 12.15
1GILD.MI Per share data1GILD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of 1GILD may justify a higher PE ratio.
PEG (NY)1.78
PEG (5Y)5.96
EPS Next 2Y8.64%
EPS Next 3Y8.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. 1GILD.MI Dividend Analysis

5.1 Amount

  • 1GILD has a Yearly Dividend Yield of 2.26%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.64, 1GILD pays a better dividend. On top of this 1GILD pays more dividend than 91.57% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, 1GILD has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

  • The dividend of 1GILD has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 12.00% of the earnings are spent on dividend by 1GILD. This is a low number and sustainable payout ratio.
  • The dividend of 1GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
1GILD.MI Yearly Income VS Free CF VS Dividend1GILD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
1GILD.MI Dividend Payout.1GILD.MI Dividend Payout, showing the Payout Ratio.1GILD.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1GILD.MI Fundamentals: All Metrics, Ratios and Statistics

GILEAD SCIENCES INC

BIT:1GILD (3/23/2026, 7:00:00 PM)

118.84

-9.48 (-7.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners92.51%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap147.53B
Revenue(TTM)N/A
Net Income(TTM)8.11B
Analysts81.05
Price Target134.53 (13.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly Dividend2.81
Dividend Growth(5Y)3.3%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)0%
PT rev (3m)5.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.52%
EPS NY rev (1m)0%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.33%
Valuation
Industry RankSector Rank
PE 16.83
Fwd PE 15.38
P/S 5.85
P/FCF 17.88
P/OCF 17.61
P/B 7.93
P/tB N/A
EV/EBITDA 12.15
EPS(TTM)7.06
EY5.94%
EPS(NY)7.72
Fwd EY6.5%
FCF(TTM)6.65
FCFY5.59%
OCF(TTM)6.75
OCFY5.68%
SpS20.3
BVpS14.98
TBVpS-3.37
PEG (NY)1.78
PEG (5Y)5.96
Graham Number48.78
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC8.41%
ROIC/WACC2.2
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.07%
EBIT Next 3Y25.58%
EBIT Next 5Y19.26%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / 1GILD.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (1GILD.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI.


What is the valuation status for 1GILD stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (1GILD.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for GILEAD SCIENCES INC?

GILEAD SCIENCES INC (1GILD.MI) has a profitability rating of 8 / 10.


What are the PE and PB ratios of GILEAD SCIENCES INC (1GILD.MI) stock?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (1GILD.MI) is 16.83 and the Price/Book (PB) ratio is 7.93.


What is the financial health of GILEAD SCIENCES INC (1GILD.MI) stock?

The financial health rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10.